|Post IPO Valuation|
|Terms||Cash and Stock|
VaxGen, Inc. operates as a biopharmaceutical company in the United States. It owns a biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that could be used to make cell culture or microbial biologic products. The company was founded in 1995 and is based in South San Francisco, California.